<SEC-DOCUMENT>0000803012-25-000014.txt : 20250630
<SEC-HEADER>0000803012-25-000014.hdr.sgml : 20250630
<ACCEPTANCE-DATETIME>20250630170637
ACCESSION NUMBER:		0000803012-25-000014
CONFORMED SUBMISSION TYPE:	144
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20250630
DATE AS OF CHANGE:		20250630

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Entrada Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001689375
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				813983399
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		144
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	001-40969
		FILM NUMBER:		251093046

	BUSINESS ADDRESS:	
		STREET 1:		ONE DESIGN CENTER PLACE
		STREET 2:		SUITE 17-500
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02210
		BUSINESS PHONE:		857-305-1825

	MAIL ADDRESS:	
		STREET 1:		ONE DESIGN CENTER PLACE
		STREET 2:		SUITE 17-500
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02210

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CycloPorters, Inc.
		DATE OF NAME CHANGE:	20161104

REPORTING-OWNER:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			5AM Ventures V, L.P.
		CENTRAL INDEX KEY:			0001674324
		ORGANIZATION NAME:           	
		EIN:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		144

	BUSINESS ADDRESS:	
		STREET 1:		4 EMBARCADERO CENTER, SUITE 3110
		CITY:			SAN FRANCISCO
		STATE:			CA
		ZIP:			94111
		BUSINESS PHONE:		(415) 993-8565

	MAIL ADDRESS:	
		STREET 1:		4 EMBARCADERO CENTER, SUITE 3110
		CITY:			SAN FRANCISCO
		STATE:			CA
		ZIP:			94111
</SEC-HEADER>
<DOCUMENT>
<TYPE>144
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
<XML>
<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/ownership" xmlns:com="http://www.sec.gov/edgar/common">
  <headerData>
    <submissionType>144</submissionType>
    <filerInfo>
      <filer>
        <filerCredentials>
          <cik>0001674324</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>



    </filerInfo>
  </headerData>
  <formData>
    <issuerInfo>
      <issuerCik>0001689375</issuerCik>
      <issuerName>Entrada Therapeutics, Inc.</issuerName>
      <secFileNumber>001-40969</secFileNumber>
      <issuerAddress>
        <com:street1>ONE DESIGN CENTER PLACE</com:street1>
        <com:street2>SUITE 17-500</com:street2>
        <com:city>BOSTON</com:city>
        <com:stateOrCountry>MA</com:stateOrCountry>
        <com:zipCode>02210</com:zipCode>
      </issuerAddress>
      <issuerContactPhone>857-305-1825</issuerContactPhone>
      <nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>5AM Ventures V, L.P.</nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
      <relationshipsToIssuer>
        <relationshipToIssuer>Director</relationshipToIssuer>
      </relationshipsToIssuer>
    </issuerInfo>
    <securitiesInformation>
      <securitiesClassTitle>Common</securitiesClassTitle>
      <brokerOrMarketmakerDetails>
        <name>TD Securities (USA) LLC</name>
        <address>
          <com:street1>1 Vanderbilt Ave</com:street1>
          <com:city>New York</com:city>
          <com:stateOrCountry>NY</com:stateOrCountry>
          <com:zipCode>10017</com:zipCode>
        </address>
      </brokerOrMarketmakerDetails>
      <noOfUnitsSold>18578</noOfUnitsSold>
      <aggregateMarketValue>126566.34</aggregateMarketValue>
      <noOfUnitsOutstanding>37953417</noOfUnitsOutstanding>
      <approxSaleDate>06/30/2025</approxSaleDate>
      <securitiesExchangeName>NASDAQ</securitiesExchangeName>
    </securitiesInformation>
    <securitiesToBeSold>
      <securitiesClassTitle>Common</securitiesClassTitle>
      <acquiredDate>09/28/2017</acquiredDate>
      <natureOfAcquisitionTransaction>Venture Investment</natureOfAcquisitionTransaction>
      <nameOfPersonfromWhomAcquired>Entrada Therapeutics, Inc.</nameOfPersonfromWhomAcquired>
      <isGiftTransaction>N</isGiftTransaction>
      <amountOfSecuritiesAcquired>18578</amountOfSecuritiesAcquired>
      <paymentDate>09/28/2017</paymentDate>
      <natureOfPayment>Cash</natureOfPayment>
    </securitiesToBeSold>
    <nothingToReportFlagOnSecuritiesSoldInPast3Months>N</nothingToReportFlagOnSecuritiesSoldInPast3Months>
    <securitiesSoldInPast3Months>
      <sellerDetails>
        <name>5AM Ventures V, L.P.</name>
        <address>
          <com:street1>4 Embarcadero Center, Suite 3110</com:street1>
          <com:city>San Francisco</com:city>
          <com:stateOrCountry>CA</com:stateOrCountry>
          <com:zipCode>94111</com:zipCode>
        </address>
      </sellerDetails>
      <securitiesClassTitle>Common</securitiesClassTitle>
      <saleDate>06/27/2025</saleDate>
      <amountOfSecuritiesSold>55735</amountOfSecuritiesSold>
      <grossProceeds>385128.85</grossProceeds>
    </securitiesSoldInPast3Months>
    <noticeSignature>
      <noticeDate>06/30/2025</noticeDate>
      <signature>Andrew J. Schwab</signature>
    </noticeSignature>
  </formData>
</edgarSubmission>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
